Search Results - "Hellemons, Merel"

Developments in lung transplantation over the past decade by van der Mark, Sophie C, Hoek, Rogier A S, Hellemons, Merel E

“…With an improved median survival of 6.2 years, lung transplantation has become an increasingly acceptable treatment option for end-stage lung disease. Besides…”
Get full text

Puzzling persisting symptoms after COVID-19 by Hellemons, Merel E

“…https://bit.ly/33nyUxl…”
Get full text

Recurrent treatment of refractory acute cellular rejection with alemtuzumab after lung transplantation by van Haren, Eva, van Vugt, Lukas K., Wijbenga, Nynke, van der Sijs, Heleen, Hellemons, Merel E.

“…We present an exceptional case of a lung transplant recipient successfully treated by multiple courses of alemtuzumab for refractory acute cellular rejection…”
Get full text

Clinical Characteristics and Outcomes of Immunocompromised Patients With Coronavirus Disease 2019 Caused by the Omicron Variant: A Prospective, Observational Study by Malahe, S Reshwan K, Hoek, Rogier A S, Dalm, Virgil A S H, Broers, Annoek E C, den Hoed, Caroline M, Manintveld, Olivier C, Baan, Carla C, van Deuzen, Charlotte M, Papageorgiou, Grigorios, Bax, Hannelore I, Van Kampen, Jeroen J, Hellemons, Merel E, Kho, Marcia M L, de Vries, Rory D, Molenkamp, Richard, Reinders, Marlies E J, Rijnders, Bart J A

“…Illness after infection with the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) Omicron variant is less severe compared with previous variants…”
Get full text

Intensive Care Unit-Specific Virtual Reality for Critically Ill Patients With COVID-19: Multicenter Randomized Controlled Trial by Vlake, Johan H, van Bommel, Jasper, Wils, Evert-Jan, Bienvenu, Joe, Hellemons, Merel E, Korevaar, Tim Im, Schut, Anna Fc, Labout, Joost Am, Schreuder, Lois Lh, van Bavel, Marten P, Gommers, Diederik, van Genderen, Michel E

“…Although psychological sequelae after intensive care unit (ICU) treatment are considered quite intrusive, robustly effective interventions to treat or prevent…”
Get full text

COVID-19 follow-up programs across Europe: an ERS END-COVID CRC survey by Valenzuela, Claudia, Nigro, Mattia, Chalmers, James D, Wagers, Scott, Avinash, Aujayeb, Hellemons, Merel E, Löffler-Ragg, Judith, Brightling, Christopher E, Aliberti, Stefano

“…SARS-CoV-2 is responsible for a multi-organ syndrome that can last over 12 months after the initial infection, which includes pulmonary and systemic…”
Get full text

COVID-19 in solid organ transplant recipients: a single-center experience by Hoek, Rogier A S, Manintveld, Olivier C, Betjes, Michiel G H, Hellemons, Merel E, Seghers, Leonard, Van Kampen, Jeroen A A, Caliskan, Kadir, van de Wetering, Jacqueline, van den Hoogen, Martijn, Metselaar, Herold J, Hesselink, Dennis A

“…Solid organ transplant (SOT) recipients may be at risk for severe COVID-19. Data on the clinical course of COVID-19 in immunosuppressed patients are limited,…”
Get more information

Lung transplant airway complications treated with biodegradable airway stents: The Dutch multi‐center experience by Pel, Roel, Gan, Tji, Daniels, Johannes M. A., Ruigrok, Dieuwertje, Hellemons, Merel E., Klooster, Karin, Slebos, Dirk‐Jan

“…Introduction Treatment of post lung‐transplant airway complications is challenging, and treatment with conventional airway stents is associated with adverse…”
Get full text

The clinical validation of a dried blood spot method for simultaneous measurement of cyclosporine A, tacrolimus, creatinine, and hematocrit by Francke, Marith I., van Domburg, Bart, Bouarfa, Samah, van de Velde, Daan, Hellemons, Merel E., Manintveld, Olivier C., Last-Koopmans, Suzanne, Mulder, Midas B., Hesselink, Dennis A., de Winter, Brenda C.M.

“…•A multicomponent dried blood spot method was clinically validated in transplant recipients.•A dried blood spot method was validated for cyclosporine A,…”
Get full text

Acute COVID-19 treatment is not associated with health problems 2 years after hospitalization by Berentschot, Julia C., Martine Bek, L., Heijenbrok-Kal, Majanka H., van den Berg-Emons, Rita J.G., Ribbers, Gerard M., Aerts, Joachim G.J.V., Hellemons, Merel E.

“…•Many patients hospitalized for COVID-19 suffer from long-term health problems.•In-hospital treatment for COVID-19 is not associated with long-term health…”
Get full text

Diagnostic performance of electronic nose technology in chronic lung allograft dysfunction by Wijbenga, Nynke, Hoek, Rogier A.S., Mathot, Bas J., Seghers, Leonard, Moor, Catharina C., Aerts, Joachim G.J.V., Bos, Daniel, Manintveld, Olivier C., Hellemons, Merel E.

“…There is a need for reliable biomarkers for the diagnosis of chronic lung allograft dysfunction (CLAD). In this light, we investigated the diagnostic value of…”
Get full text

High torque tenovirus (TTV) load before first vaccine dose is associated with poor serological response to COVID-19 vaccination in lung transplant recipients by Hoek, Rogier AS, Verschuuren, Erik AM, de Vries, Rory D, Vonk, Judith M., van Baarle, Debbie, van der Heiden, Marieke, van Gemert, Johanna P, Gore, Edmund J, Niesters, Hubert GM, Erasmus, Michiel, Hellemons, Merel E., Scherbeijn, Sandra MJ, Wijbenga, Nynke, Mahtab, Edris A.F., GeurtsvanKessel, Corine H., Buter, Coretta Van Leer

“…Serological responses to COVID-19 vaccination are diminished in recipients of solid organ transplants, especially in lung transplant recipients (LTR), probably…”
Get full text

The effect of COVID-19 on transplant function and development of CLAD in lung transplant patients: a multicenter experience by Roosma, E., van Gemert, J.P., de Zwart, A.E.S., van Leer-Buter, C.C., Hellemons, M.E., Berg, E.M., Luijk, B., Hoek, R.A.S., van Kessel, D.A., Akkerman, O.W., Kerstjens, H.A.M., Verschuuren, E.A.M., Gan, C.T.

“…Concerns have been raised on the impact of coronavirus disease (COVID-19) on lung transplant (LTx) patients. The aim of this study was to evaluate the…”
Get full text

Antibodies against angiotensin II receptor type 1 and endothelin A receptor are increased in COVID-19 patients by Miedema, Jelle R., Janssen, Matthijs L., Thüsen, Jan von der, Endeman, Henrik, Langerak, Anton W., Hellemons, Merel E., van Nood, Els, Peeters, Bas W. A., Baart, Sara J., Schreurs, Marco W. J.

“…Background Increased titers of autoantibodies targeting the G-protein-coupled receptors angiotensin II type 1 receptor (AT1R) and endotelin-1 type A receptor…”
Get full text

Desquamative interstitial pneumonia: a systematic review of its features and outcomes by Hellemons, Merel E, Moor, Catharina C, von der Thüsen, Jan, Rossius, Mariska, Odink, Arlette, Thorgersen, Laila Haugen, Verschakelen, Johny, Wuyts, Wim, Wijsenbeek, Marlies S, Bendstrup, Elisabeth

“…Desquamative Interstitial Pneumonia (DIP) is a rare form of idiopathic interstitial pneumonia (IIP). Data on clinical features, aetiology, prognosis and effect…”
Get full text

Humoral and cellular immune responses after COVID-19 vaccination of lung transplant recipients and patients on the waiting list: a 6-month follow-up by Hoek, Rogier A S, Liu, Siqi, GeurtsvanKessel, Corine H, Verschuuren, Erik A M, Vonk, Judith M, Hellemons, Merel E, Kool, Mirjam, Wijbenga, Nynke, Bogers, Susanne, Scherbeijn, Sandra, Rugebregt, Sharona, van Gemert, Johanna P, Steenhuis, Willie N, Niesters, Hubert G M, van Baarle, Debbie, de Vries, Rory D, Van Leer Buter, Coretta

“…Data on cellular response and the decay of antibodies and T cells in time are scarce in lung transplant recipients (LTRs). Additionally, the development and…”
Get full text

Effect of intensive care unit-specific virtual reality (ICU-VR) to improve psychological well-being and quality of life in COVID-19 ICU survivors: a study protocol for a multicentre, randomized controlled trial by Vlake, Johan H, Van Bommel, Jasper, Wils, Evert-Jan, Korevaar, Tim I M, Hellemons, Merel E, Schut, Anna F C, Labout, Joost A M, Schreuder, Lois L H, Gommers, Diederik, Van Genderen, Michel E

“…The SARS-CoV-2 outbreak has resulted in a tremendous increase in hospital and intensive care unit (ICU) admissions all over the world. Patients with severe…”
Get full text

Adalimumab for Crohn's disease: Long-term sustained benefit in a population-based cohort of 438 patients by Peters, Charlotte P., Eshuis, Emma J., Toxopeüs, Florien M., Hellemons, Merel E., Jansen, Jeroen M., D'Haens, Geert R.A.M., Fockens, Paul, Stokkers, Pieter C.F., Tuynman, Hans A.R.E., van Bodegraven, Adriaan A., Ponsioen, Cyriel Y.

“…Adalimumab is an effective therapy for induction and maintenance of Crohn's disease. However, results in clinical trials don't necessarily reflect daily…”
Get full text

Long-term outcome and bridging success of patients evaluated and bridged to lung transplantation on the ICU by Gan, C.Tji, Hoek, Rogier A.S., van der Bij, Wim, Van De Wauwer, Caroline, Erasmus, Michiel E., Oude Lansink-Hartgring, Annemiek, Droogh, Joep M., Seghers, Leonard, Mathot, Bas J., Mahtab, Edris A.F., Bekkers, Jos A., Dos Reis Miranda, Dinis, Verschuuren, Erik A.M., Hellemons, Merel E.

“…Evaluating and bridging patients to lung transplantation (LTx) on the intensive care unit (ICU) remains controversial, especially without a previous waitlist…”
Get full text

Home monitoring of lung function, symptoms and quality of life after admission with COVID‐19 infection: The HOMECOMIN' study by Nakshbandi, Gizal, Moor, Catharina C., Nossent, Esther J., Geelhoed, J. J. Miranda, Baart, Sara J., Boerrigter, Bart G., Aerts, Joachim G. J. V., Nijman, Suzan F. M., Santema, Helger Y., Hellemons, Merel E., Wijsenbeek, Marlies S.

“…Background and objective To develop targeted and efficient follow‐up programmes for patients hospitalized with coronavirus disease 2019 (COVID‐19), structured…”
Get full text